Skip to Main Content

Paper Details

Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy.
Int J Radiat Oncol Biol Phys
33
2019
22-feature genomic classifier, Cancer, GC, IR, IR-PCa, androgen, intermediate-risk prostate cancer, men, patients, prostate-specific antigen, tumors
Aged, Genomics, Humans, Male, Neoplasm Metastasis, Prostatic Neoplasms, Radiotherapy Dosage, Radiotherapy, Image-Guided
Author NameAffiliation
Alejandro BerlinPrincess Margaret Cancer Centre, University Health Network, University of Toronto, Canada Techna Institute
Jure MurgicPrincess Margaret Cancer Centre, University Health Network
Ali HosniPrincess Margaret Cancer Centre, University Health Network
Melania PintiliePrincess Margaret Cancer Centre, University Health Network
Adriana SalcedoOntario Institute for Cancer Research, University of Toronto
Michael FraserOntario Institute for Cancer Research
Suzanne Kamel-ReidUniversity Health Network
Jingbin ZhangGenomeDx Biosciences Inc.
Qiqi WangGenomeDx Biosciences Inc.
Carolyn Ch'ngGenomeDx Biosciences Inc.
Samineh DeheshiGenomeDx Biosciences Inc.
Elai DavicioniGenomeDx Biosciences Inc.
Theodorus H van der KwastUniversity Health Network
Paul C BoutrosOntario Institute for Cancer Research, University of Toronto
Robert G BristowPrincess Margaret Cancer Centre, University Health Network, University of Toronto, Canada Manchester Cancer Research Centre
Melvin L K ChuaPrincess Margaret Cancer Centre, University Health Network, National Cancer Centre Singapore, Duke-NUS Medical School
  • 1 - 16

Datasets

Release 1.2